TGF-β is capable of recognizing itself adequately, foreign or tumor-associated antigens, and inhibits the production and/or effects of proinflammatory cytokines (such as IL-1α, IL-6, and TNF-α) [29, 30]. The gene discussed is IL1A; the disease is neoplasm.